Turner Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-300
Closed -$24K 279
2016
Q3
$24K Hold
300
0.01% 177
2016
Q2
$24K Hold
300
0.01% 195
2016
Q1
$22K Sell
300
-91,590
-100% -$6.93M 0.01% 202
2015
Q4
$7.74M Buy
91,890
+10,000
+12% +$830K 1.6% 7
2015
Q3
$6.85M Buy
+81,890
New +$6.91M 1.39% 9
2015
Q2
Sell
-500
Closed -$36K 332
2015
Q1
$36K Buy
+500
New +$35.6K 0.01% 323
2014
Q2
Sell
-73,170
Closed -$4.31M 609
2014
Q1
$4.31M Buy
+73,170
New +$4.08M 0.11% 223

Other funds holding LLY

Turner Investments's LLY Position: Q4 2016 in Review

Turner Investments sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 300 shares — an estimated $24K sold.

Turner Investments first reported a position in LLY in Q1 2014 and held it in 7 quarters. The position peaked at $7.74M in Q4 2015. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • Turner Investments reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
  • Turner Investments sold 300 Eli Lilly shares in Q4 2016, an estimated $24K.
  • Turner Investments first reported a position in Eli Lilly in Q1 2014 and held it in 7 quarters.
  • Turner Investments's Eli Lilly position peaked at $7.74M in Q4 2015.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.